ResMed (RMD)

EBITDA Growth

-5.36%

Quarterly · Period ending:

RMD logo

RMD EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-5.36%
RMD Quarterly EBITDA YoY % (84.21% → -5.36%)
High-resolution chart · PNG

RMD ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

ResMed EBITDA Growth — Quarterly
Period endingEBITDA Growth
-5.3552%
24.2815%
18.2488%
15.9351%
46.911%
5.662%
21.9816%
29.983%
6.1268%
24.447%
17.5214%
8.8283%
18.2925%
26.0214%
14.105%
0.383%
-0.5499%
4.4532%
5.1649%
16.8612%
8.7838%
2.7818%
18.7682%
24.0746%
76.8052%
32.8279%
17.6806%
23.1805%
-18.9137%
12.5256%
13.5926%
22.8152%
21.5524%
22.7906%
38.7876%
15.371%
5.1085%
15.785%
-7.3566%
5.8105%
24.1847%
0.3976%
24.9776%
2.7998%
-22.0277%
1.5163%
-11.6942%
-1.3045%
5.559%
4.3726%
10.9844%
15.7506%
-7.1495%
20.9156%
23.4011%
21.9662%
80.1303%
17.6555%
3.4729%
-2.1099%
5.072%
4.8368%
16.5998%
22.5497%
7.6962%
49.0822%
33.3345%
33.0604%
46.1028%
-3.0783%
10.7424%
5.1%
4.7819%
662.4455%
24.4938%
37.1928%
0.6693%
-126.2185%
-3.8355%
0.0283%
26.3918%
1.8093%
26.703%
22.7864%
33.2139%
60.4731%
72.2116%
51.7041%
34.6918%
9.7443%
0.4767%
2.5427%
124.4813%
32.716%
20.5936%
17.5977%
-1,010.0517%
-4.1405%
38.3199%
41.9745%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.